Protein kinase C isozymes in hypertension and hypertrophy: Insight from SHHF rat hearts

Molecular and Cellular Biochemistry

Volumn 270, Issue 1-2, 2005, Pages 63-69

  Johnsen, Dustin D ^a   Kacimi, Rachid ^a   Anderson, Brent E ^a   Thomas, Tracy A ^a   Said, Suleman ^a   Gerdes, A Martin ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Angiotensin II type 1 receptor; Cardiac hypertrophy; Hydralazine; Protein kinase C; Signal transduction; Spontaneously hypertensive heart failure rat

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ENZYME ANTIBODY; HYDRALAZINE; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; PROTEIN EXPRESSION; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOTTING, WESTERN; ENZYME ACTIVATION; FEMALE; HEART; HEART VENTRICLES; HYDRALAZINE; HYPERTENSION; HYPERTROPHY; MYOCARDIUM; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; RATS; RATS, INBRED SHR; RATS, INBRED WF; SIGNAL TRANSDUCTION;

EID: 15844364017     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-3781-x     Document Type: Article

References (36)

1. q, PLC βI, and PKC. Cardiovasc Res 44: 5-9, 1999
2. 2+ -sensitive isoforms in the failing human heart. Circulation 99 384-391 1999
3. Wang J, Liu X, Sentex E, Takeda N, Dhalla NS: Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol 284: H2277-H2287, 2003
4. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, et al.: PKC α regulates contractility and propensity toward heart failure. Nat Med 10: 248-254, 2004
5. Naruse K, King GL: Protein kinase C and myocardial biology and function. Circ Res 86: 1104-1106, 2000
6. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, et al.: Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279: L429-L438, 2000
7. Ping P: A new chapter in cardiac PKC signaling studies: Searching for isoform-specific molecular targets. Focus on: "Isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes". Am J Physiol Cell Physiol 285: C19-C21, 2003
8. Pucéat M, Hilal-Dandan R, Strulovici B, Brunton LL, Brown JH: Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem 269: 16938-16944, 1994
9. Mochly-Rosen D, Wu G, Hahn H, Osinska H, Liron T, Lorenz JN, et al.: Cardiotrophic effects of protein kinase C ε. Analysis by in vivo modulation of PKCε translocation. Circ Res 86: 1173-1179, 2000
10. Parekh DB, Ziegler W, Parker PJ: Multiple pathways control protein kinase C phosphorylation. EMBO J 19: 496-503, 2000
11. Heyen JR, Blasi ER, Nikula K, Rocha R, Daust HA, Frierdich G, et al.: Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol 283: H1775-H1784, 2002
12. Gerdes AM, Onodera T, Wang X, McCune SA: Myocyte remodeling during the progression to failure in rats with hypertension. Hypertension 28: 609-614, 1996
13. Kacimi R, Gerdes AM: Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension 41: 968-977, 2003
14. Anderson KM, Eckhart AD, Willette RN, Koch WJ: The myocardial β-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension 33: 402-407, 1999
15. Chang RS, Siegl PK, Clineschmidt BV, et al.: In vivo pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist. J Pharmacol Exp Ther 262: 133-138, 1992
16. Ron D, Kazanietz MG: New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 13: 1658-1676, 1999
17. Hahn HS, Yussman MG, Toyokawa T, Marreez Y, Barrett TJ, Hilty KC, et al.: Ischemic protection and myofibrillar cardiomyopathy. Dose-dependent effects of in vivo αPKC inhibition. Circ Res 91: 741-748, 2002 10.1161/01.RES.0000037091.64492.69
18. Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoit BD, Walsh RA: Transgenic overexpression of constitutively active protein kinase C ε causes concentric cardiac hypertrophy. Circ Res 86: 1218-1223, 2000 1:CAS:528:DC%2BD3cXks1Kmtro%3D
19. Kerkela R, Ilves M, Pikkarainen S, Tokola H, Ronkainen J, Vuolteenaho O, et al.: Identification of PKCα isoform-specific effects in cardiac myocytes using antisense phosphorothioate oligonucleotides. Mol Pharmacol 62: 1482-1491, 2002
20. Clerk A, Sugden PH: Untangling the web. Specific signaling from PKC isoforms to MAPK cascades. Circ Res 89: 847-849, 2001
21. Akita Y: Protein kinase C-ε (PKC-ε): Its unique structure and function. J Biochem 132: 847-852, 2002
22. Wu G, Toyokawa T, Hahn H, Dorn GW: ε Protein kinase C in pathologic myocardial hypertrophy. J Biol Chem 275: 29927-29930, 2000
23. Inagaki K, Iwanaga Y, Sarai N, Onozawa Y, Takenda H, Mochly-Rosen D, et al.: Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKCε and PKCβ. J Mol Cell Cardiol 34: 1377-1385, 2002
24. Onodera T, Tamura T, Said S, McCune SA, Gerdes AM: Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension 32: 753-757, 1998
25. Bayer AL, Heidkamp MC, Patel N, Porter M, Engman S, Samarel AM: Alterations in protein kinase C isoenzyme expression and autophosphorylation during the progression of pressure overload-induced left ventricular hypertrophy. Mol Cell Biochem 242: 145-152, 2003
26. Simonis G, Honold J, Schwarz K, Braun MU, Strasser RH: Regulation of the isozymes of protein kinase C in the surviving rat myocardium after myocardial infarction: Distinct modulation for PKC-α and for PKC-α. Basic Res Cardiol 97: 223-231, 2002
27. Rybin VO, Steinberg SF: Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 74: 229-309, 1994
28. Takeishi Y, Jalili T, Ball NA, Walsh RA: Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated. Circ Res 85: 264-271, 1999 1:CAS:528:DyaK1MXltFGgsL0%3D
29. Sadoshima J, Izumo S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73: 413-423, 1993 1:CAS:528:DyaK3sXmtFygs74%3D
30. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984, 1993
31. Harada K, Issei K, Shiojima I, Hayashi D, Kudoh S, Mizuno T, et al.: Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 97: 1952-1959, 1998
32. Kudoh S, Komuro I, Hiroi Y, Zou Y, Harada K, Sugaya T, et al.: Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1A receptor knockout mice. J Biol Chem 273: 24037-24043, 1998
33. Paul K, Ball NA, Dorn GW, Walsh RA: Left ventricular stretch stimulates angiotensin II-mediated phosphatidylinositol hydrolysis and protein kinase C ε isoform translocation in adult guinea pig hearts. Circ Res 81: 643-650, 1997
34. Sabri A, Steinberg SF: Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure. Mol Cell Biochem 251: 97-101, 2003
35. Tamura T, Said S, Harris J, Lu W, Gerdes AM: Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system. Circulation 102: 253-259, 2000
36. Tamura T, Said S, Andersen SMK, McCune SA, Mochizuki S, Gerdes AM: Temporal regression of myocyte hypertrophy in hypertensive, heart failure-prone rats treated with an AT1-receptor antagonist. J Cardiac Failure 8: 43-47, 2002